会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Amino acid derivatives and their use as anti-viral agents
    • Aminosäurederivateund ihre Verwendung als antiviral Wirkstoffe。
    • EP0512343A2
    • 1992-11-11
    • EP92107090.0
    • 1992-04-25
    • F. HOFFMANN-LA ROCHE AG
    • Martin, Joseph ArmstrongThomas, Gareth John
    • C07C271/22A61K31/27C07C237/24C07C323/60C07D215/48A61K31/16A61K31/47
    • C07C271/22C07C237/24C07C255/29C07C323/60C07C2601/14C07D215/48
    • Compounds of the formula

      wherein R 1 represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aralkanoyl, heterocyclylcarbonyl or a group of the formula


      R 2 represents alkyl, cycloalkylalkyl or aralkyl; R 3 represents hydrogen and R 4 represents hydroxy or R 3 and R 4 together represent oxo; R 5 represents alkoxycarbonyl or alkylcarbamoyl; R 6 and R 7 together represent trimethylene or tetramethylene optionally substituted by alkyl or on adjacent carbon atoms by tetramethylene; R 8 represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aroyl, aralkanoyl or heterocyclylcarbonyl; and R 9 represents alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, cyanoalkyl, carbamoylalkyl, alkylthioalkyl, alkoxyalkyl or alkoxycarbonylalkyl,
      and pharmaceutically acceptable acid addition salts of those compounds of formula I which are basic, inhibit aspartyl proteases of viral origin and can be used in the form of medicaments for the prophylaxis or treatment of viral infections. They can be manufactured according to generally known methods.
    • 其中R 1表示烷氧基羰基,芳烷氧羰基,烷酰基,芳烷酰基,杂环基羰基或式CH 2 R 2基团的化合物代表烷基,环烷基烷基或芳烷基; R 3表示氢,R 4表示羟基或R 3,R 4一起表示氧代; R 5表示烷氧基羰基或烷基氨基甲酰基; R 6和R 7一起表示任选被烷基或相邻碳原子上被四亚甲基取代的三亚甲基或四亚甲基; R 8表示烷氧基羰基,芳烷氧基羰基,烷酰基,芳酰基,芳烷酰基或杂环基羰基; 并且R 9表示烷基,环烷基,环烷基烷基,芳烷基,氰基烷基,氨基甲酰基烷基,烷硫基烷基,烷氧基烷基或烷氧基羰基烷基,以及那些碱式的式I化合物的药学上可接受的酸加成盐,可抑制病毒来源的天冬氨酰蛋白酶 以用于预防或治疗病毒感染的药物的形式。 它们可以根据通常已知的方法制造。
    • 8. 发明公开
    • Amino acid derivatives and their use as anti-viral agents
    • 氨基酸衍生物及其用作反病毒剂
    • EP0512343A3
    • 1993-03-24
    • EP92107090.0
    • 1992-04-25
    • F. HOFFMANN-LA ROCHE AG
    • Martin, Joseph ArmstrongThomas, Gareth John
    • C07C271/22A61K31/27C07C237/24C07C323/60C07D215/48A61K31/16A61K31/47
    • C07C271/22C07C237/24C07C255/29C07C323/60C07C2601/14C07D215/48
    • Compounds of the formula

      wherein R 1 represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aralkanoyl, heterocyclylcarbonyl or a group of the formula
      R 2 represents alkyl, cycloalkylalkyl or aralkyl; R 3 represents hydrogen and R 4 represents hydroxy or R 3 and R 4 together represent oxo; R 5 represents alkoxycarbonyl or alkylcarbamoyl; R 6 and R 7 together represent trimethylene or tetramethylene optionally substituted by alkyl or on adjacent carbon atoms by tetramethylene; R 8 represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aroyl, aralkanoyl or heterocyclylcarbonyl; and R 9 represents alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, cyanoalkyl, carbamoylalkyl, alkylthioalkyl, alkoxyalkyl or alkoxycarbonylalkyl, and pharmaceutically acceptable acid addition salts of those compounds of formula I which are basic, inhibit aspartyl proteases of viral origin and can be used in the form of medicaments for the prophylaxis or treatment of viral infections. They can be manufactured according to generally known methods.
    • 其中R 1表示烷氧基羰基,芳烷氧羰基,烷酰基,芳烷酰基,杂环基羰基或式CH 2 R 2基团的化合物代表烷基,环烷基烷基或芳烷基; R 3表示氢,R 4表示羟基或R 3,R 4一起表示氧代; R 5表示烷氧基羰基或烷基氨基甲酰基; R 6和R 7一起表示任选被烷基或相邻碳原子上被四亚甲基取代的三亚甲基或四亚甲基; R 8表示烷氧基羰基,芳烷氧基羰基,烷酰基,芳酰基,芳烷酰基或杂环基羰基; 并且R 9表示烷基,环烷基,环烷基烷基,芳烷基,氰基烷基,氨基甲酰基烷基,烷硫基烷基,烷氧基烷基或烷氧基羰基烷基,以及那些碱式的式I化合物的药学上可接受的酸加成盐,可抑制病毒来源的天冬氨酰蛋白酶 以用于预防或治疗病毒感染的药物的形式。 它们可以根据通常已知的方法制造。